WinstonWınston
AddLife AB Class B logo

AddLife AB Class B

0REZ.L
50
Medical - Care Facilities · Healthcare
Price
162.50 GBp
-6.30 (-3.73%)
Market Cap
£19.80B
Exchange
London Stock Exchange
Winston Score
50
Winston is curious
Mixed quality — meaningful strengths and weaknesses.

Share count rising — dilution

+1.6% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 120.0M (2021) → 121.9M (2025)

AddLife AB is a Swedish company that distributes medical and laboratory equipment across Europe. It sells products like diagnostic tools, surgical instruments, and lab supplies to hospitals, clinics, and research laboratories. The company acts as a middleman between manufacturers and healthcare providers, and it has grown largely by acquiring smaller specialty distributors over time.

AddLife makes money by buying products from manufacturers and reselling them at a markup, earning a gross margin of around 38%. It operates mainly in the Nordic countries and broader Europe, with hundreds of employees spread across many subsidiaries. The company's competitive edge comes from its network of specialized local businesses, which build deep relationships with customers in niche medical and life science markets. The main risk is that its acquisition-driven growth strategy depends on finding and integrating new companies successfully, and rising interest rates or a slowdown in healthcare spending could pressure both deal activity and profit margins.

Winston Score History

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
38.7%
Modest — 38.7% gross margin
Operating Margin
8.8%
Modest — 8.8% operating margin
ROCE
2.2%
Weak — 2.2% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-0.3%
Shrinking sales (-0.3% YoY)
EPS YoY
+83.1%
Earnings growing fast (83.1% YoY)

Earnings growing 25%+ a year. The compounder zone.

EPS Consistency
8/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
221%
Turns 221% of profit into real cash
FCF Margin
9.8%
Modest free cash flow (9.8%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.85
Moderate — manageable debt (0.85)
Interest Cover
3.90x
Tight — interest eats into profit (3.9x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
34.9x
Pricey — P/E 34.9

P/E above the market average. People are paying up for expected growth.

P/E vs Forward
+2.2
GROWING
Earnings expected to grow — slightly cheaper on forward P/E

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
0.88%
Small dividend — 0.88% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend Growth
-89.9%
Dividend cut (-89.9% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial